Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
147 studies found for:    dengue
Show Display Options
Rank Status Study
81 Recruiting The Use of Biomarkers in Predicting Dengue Outcome
Condition: Dengue
Intervention:
82 Completed Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease
Condition: Dengue Fever
Interventions: Biological: DENV-1 PIV, 2.5 µg;   Biological: DENV-1 PIV, 5 µg
83 Completed
Has Results
A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers
Condition: Healthy
Interventions: Biological: Takeda's Tetravalent Dengue Vaccine Candidate (TDV);   Biological: TDV New Formulation;   Drug: Placebo;   Drug: New Formulation Placebo
84 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults
Condition: Dengue Fever
Intervention: Biological: rDEN3delta30/31‐7164
85 Completed Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: rDEN1delta30;   Biological: Placebo
86 Completed Role of Andi-d in Dengue Fever: a Pilot Study
Condition: Dengue Fever
Intervention: Drug: anti-d
87 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN3/4delta30(ME);   Biological: Placebo
88 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN4delta30-4995;   Biological: Placebo
89 Completed Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
90 Completed A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand
Condition: Dengue
Interventions: Biological: T-DEN F17;   Biological: T-DEN F-19;   Other: Placebo Comparator
91 Completed Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine-Admixture 1;   Biological: TetraVax-DV Vaccine-Admixture 2;   Biological: TetraVax-DV Vaccine-Admixture 3;   Biological: TetraVax-DV Vaccine-Admixture 4;   Biological: Placebo;   Biological: TetraVax-DV Vaccine-Admixture 5
92 Active, not recruiting Factors Associated With Poor Dengue Outcomes in Malaysia
Condition: Dengue Fever
Intervention:
93 Active, not recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
Condition: Dengue Fever
Interventions: Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant;   Biological: Biological/Vaccine: 1 µg TDENV-PIV with AS03B adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E adjuvant
94 Withdrawn Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
Conditions: Dengue;   Disease Progression
Intervention: Other: diagnostic bedside ultrasound
95 Active, not recruiting Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults
Condition: Dengue
Interventions: Biological: TV005;   Biological: Placebo;   Biological: rDEN2∆30-7169
96 Recruiting Efficacy and Safety of Ivermectin Against Dengue Infection
Condition: Dengue Fever
Interventions: Drug: 2 days Ivermectin;   Drug: 3 days Ivermectin;   Drug: Placebo
97 Not yet recruiting Safety and Immunogenicity of Takeda's TDV in Healthy Children
Condition: Healthy Volunteers
Intervention: Biological: Tetravalent Dengue Vaccine Candidate
98 Active, not recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: 4 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS03B1 adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E1 adjuvant
99 Completed Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN2Δ30-7169 vaccine;   Biological: Placebo
100 Recruiting Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN1Δ30;   Biological: Placebo;   Biological: rDEN2Δ30-7169

First Page    Show previous page of results Previous Page (61-80) Studies Shown (81-100) Next Page (101-120) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.